The veterinary diagnostic equipment market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be attributed to factors such as heightened awareness of pet healthcare, preparedness for global pandemics, an increased emphasis on animal disease surveillance and control, and the growing popularity of pet insurance. Notable trends expected during this period encompass the adoption of digital technologies, the integration of telemedicine, the use of point-of-care testing, the utilization of artificial intelligence (AI) and machine learning, and a shift towards more eco-friendly practices within the veterinary diagnostic equipment industry.
The rising prevalence of diseases among animals serves as a significant driver of the veterinary diagnostic equipment market. As the incidence of diseases in both livestock and pets increases, there is a corresponding surge in demand for advanced diagnostic equipment. For instance, in July 2023, reports from the World Health Organization (WHO), a specialized agency of the United Nations focused on global public health, indicated that H5N1 high pathogenicity avian influenza outbreaks had been reported in poultry and wild birds across 67 countries on five continents. These outbreaks resulted in the loss of over 131 million domestic birds due to death or culling in affected farms and communities in 2022. This heightened prevalence of diseases in animals significantly drives the demand for diagnostic equipment, thereby propelling the veterinary diagnostic equipment market.
The primary categories of veterinary diagnostic equipment include hematology, immunodiagnostics, clinical chemistry, and molecular testing. Hematology involves the study of diseases related to blood, encompassing the prognosis, causes, and treatment of such conditions. Veterinary diagnostic equipment is employed in a range of settings, including hospitals, clinics, reference laboratories, universities, research centers, and for point-of-care or in-house testing, catering to both livestock like cattle and domestic pets.
The veterinary diagnostic equipment research report is one of a series of new reports that provides veterinary diagnostic equipment statistics, including veterinary diagnostic equipment industry global market size, regional shares, competitors with veterinary diagnostic equipment share, detailed veterinary diagnostic equipment segments, market trends and opportunities, and any further data you may need to thrive in the veterinary diagnostic equipment industry. This veterinary diagnostic equipment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The increasing number of veterinary practitioners is anticipated to drive the growth of the veterinary diagnostic equipment market in the upcoming years. Veterinary practitioners are professionals working in the field of veterinary medicine, which involves the diagnosis, treatment, and prevention of diseases, disorders, and injuries in animals. These practitioners rely on a range of diagnostic tools and instruments to assess and treat animals effectively. The use of veterinary diagnostic equipment has gained greater significance in veterinary medicine due to its ability to enhance the precision and efficiency of both diagnosis and treatment. For example, as of June 2022, data from the Veterinary Practitioners Registration Board of Victoria, an organization in Australia responsible for regulating practicing veterinarians, indicated a total of 3,781 registered veterinarians on their list, representing a 2.11% increase from the previous year. This growth in the number of veterinary practitioners is a driving force behind the veterinary diagnostic equipment market.
Veterinary diagnostic equipment is associated with a high cost, which can pose a substantial financial challenge for veterinary clinics and hospitals. Establishing and maintaining a testing facility equipped with blood analysis machines, physiological monitors like ECGs, anesthetic monitors, and various diagnostic imaging technologies such as X-rays, ultrasound, and MRI scanners requires significant capital investment. While certain types of veterinary diagnostic equipment may be available at a lower cost, they may offer less precision in diagnosis and, consequently, lead to less effective treatments and outcomes. The substantial expenses involved in acquiring this equipment serve as a barrier to the growth of the veterinary diagnostic equipment market.
Veterinary diagnostic equipment manufacturers are at the forefront of introducing advanced technologies, such as state-of-the-art blood microsampling techniques, to enhance precision in diagnosis and offer patient-centric specimen collection methods for detecting diseases in animals. Blood microsampling is an innovative approach that simplifies the process of drawing blood samples from livestock and companion animals, which are then sent to laboratories for further analysis. This technique is an evolution of dry blood sampling, a method for blood collection. For example, Neoteryx introduced the '3Rs-compliant Mitra' microsampling device, which operates on microsampling principles. This device leverages Neoteryx's patented Volumetric Absorptive Micro Sampling (VAMS) technology, enabling more convenient and accurate remote blood sampling. Other companies in the veterinary diagnostic equipment sector are also investing in the microsampling trend, with Diatron introducing the Diatron Aquila hematology analyzer.
Leading companies in the veterinary diagnostic equipment market are prioritizing the development of innovative products, particularly novel diagnostic tests for kidney injury, to better serve the needs of their existing customer base. A novel diagnostic test for kidney injury refers to a groundbreaking medical test that offers a more accurate, sensitive, and specific means of identifying and evaluating renal damage or injury compared to existing diagnostic methods. Such tests often incorporate emerging technologies, novel biomarkers, or innovative techniques that significantly improve early diagnosis and the accurate assessment of kidney damage, ultimately leading to improved care and outcomes. For example, in June 2023, IDEXX Laboratories Inc., a US-based company specializing in the development, manufacturing, and distribution of products and services for companion animals, poultry, livestock, water testing, and the dairy industry, launched the IDEXX Cystatin B Test. This veterinary diagnostic test is designed to identify kidney damage in cats and dogs and is integrated into renal health test panels, providing new clinical insights for approximately two million patient visits each year. The IDEXX Cystatin B Test is set to enhance our understanding of kidney health by detecting damage and offering valuable information, especially when alterations in kidney function are not readily apparent.
In September 2021, the Chinese company Mindray, specializing in veterinary imaging equipment, acquired HyTest Invest Oy and its affiliated companies for an undisclosed sum. This acquisition provided Mindray with advanced research and development capabilities in raw materials and innovation, further enhancing its investment in research and development. Additionally, it bolstered Mindray's competitive position in the veterinary diagnostic equipment sector. HyTest is the Finnish-based company specializes in veterinary diagnostic equipment.
Major companies operating in the veterinary diagnostic equipment market include IDEXX Laboratories Inc., ABAXIS Inc., HESKA Corporation, Zoetis Inc., Virbac, Mindray Medical International Limited, Neogen Corporation, QIAGEN N.V., Agfa Healthcare, Toshiba, Carestream Health, MinXray, Diagnostic Imaging Systems, BCF Technology, Sedecal, Kaixin Group Co. Ltd., Esaote S.p.A., Pfizer Inc., Thermo Fisher Scientific Inc., Henry Schein Inc., Idvet, BioMérieux SA, Randox Laboratories Ltd., Abbott Laboratories, Acon Laboratories Inc., Animal Biome, BioCHEK BV, Chison Medical Imaging Co. Ltd., DCN Dx Daignostics, General Electric Company, Hallmarq Veterinary Imaging Ltd., INDICAL Bioscience GmbH, MI:RNA Ltd., Scopio Labs Ltd., VCA Antech Inc.
North America was the largest region in the veterinary diagnostic equipment market in 2023. Asia-Pacific was the second-largest region in the global veterinary diagnostic equipment market analysis. The regions covered in the veterinary diagnostic equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the veterinary diagnostic equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The veterinary diagnostic equipment market consists of sales of testing reagents and kits, blood pressure monitoring devices, stethoscopes, and electrocardiograms. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Veterinary Diagnostic Equipment Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on veterinary diagnostic equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for veterinary diagnostic equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
- Markets Covered: 1) By Product: Hematology; Immunodiagnostics; Clinical Chemistry; Molecular Testing; 2) By Animal: Livestock Cattle; Domestic Pets; 3) By End Users: Hospitals And Clinics; Reference Laboratories; Universities/Research Centers; Point-Of-Care/In-House Testing
- Companies Mentioned: IDEXX Laboratories Inc.; ABAXIS Inc.; HESKA Corporation; Zoetis Inc.; Virbac
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- IDEXX Laboratories Inc.
- ABAXIS Inc.
- HESKA Corporation
- Zoetis Inc.
- Virbac
- Mindray Medical International Limited
- Neogen Corporation
- QIAGEN N.V.
- Agfa Healthcare
- Toshiba
- Carestream Health
- MinXray
- Diagnostic Imaging Systems
- BCF Technology
- Sedecal
- Kaixin Group Co. Ltd.
- Esaote S.p.A.
- Pfizer Inc.
- Thermo Fisher Scientific Inc.
- Henry Schein Inc.
- Idvet
- BioMérieux SA
- Randox Laboratories Ltd.
- Abbott Laboratories
- Acon Laboratories Inc.
- Animal Biome
- BioCHEK BV
- Chison Medical Imaging Co. Ltd.
- DCN Dx Daignostics
- General Electric Company
- Hallmarq Veterinary Imaging Ltd.
- INDICAL Bioscience GmbH
- MI:RNA Ltd.
- Scopio Labs Ltd.
- VCA Antech Inc.
Methodology
LOADING...